Renbing Jia
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 4
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
-
- Immunotherapy and Immune Responses 2
-
- Peptidase Inhibition and Analysis 2
-
- Autophagy in Disease and Therapy 3
-
- Ocular Oncology and Treatments 3
-
- Virus-based gene therapy research 2
- Partner nations
- ChinaNetherlands
In The Last Decade
Renbing Jia
16 papers receiving 934 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 389
- Molecular Biology 682
- Immunology 125
- Oncology 154
- Geriatrics and Gerontology 13
Countries citing papers authored by Renbing Jia
This map shows the geographic impact of Renbing Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renbing Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renbing Jia more than expected).
Fields of papers citing papers by Renbing Jia
This network shows the impact of papers produced by Renbing Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renbing Jia. The network helps show where Renbing Jia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Renbing Jia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 21 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 13 | |
| 11 | 2024 | 14 | |
| 12 | 2023 | 42 | |
| 13 | Metformin and cancer hallmarks: shedding new lights on therapeutic repurposingbreakdown → | 2023 | 105 |
| 14 | 2023 | 80 | |
| 15 | 2022 | 22 | |
| 16 | Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanomabreakdown → | 2021 | 603 |
| 17 | 2019 | 7 | |
| 18 | 2018 | 19 | |
| 19 | 2018 | 6 | |
| 20 | [Continuous funding of National Natural Science Foundation of China has boosted the development of the discipline of ophthalmology over the past 25 years]. | 2012 | 1 |
About Renbing Jia
Renbing Jia is a scholar working on Cancer Research, Ophthalmology and Geriatrics and Gerontology, having authored 20 papers that have together received 938 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers), Autophagy in Disease and Therapy (3 papers), Ocular Oncology and Treatments (3 papers), Virus-based gene therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Cancer Research (389 citations), Molecular Biology (682 citations) and Immunology (125 citations). Renbing Jia has collaborated with scholars based in China and Netherlands. Frequent co-authors include Shengfang Ge, Xianqun Fan, Peiwei Chai, Jie Yu, Jing Ruan, Minyue Xie, Ai Zhuang, Yiran Yao, Xiang Gu and Ludi Yang. Their work appears in journals such as Nucleic Acids Research, Genome biology and Biotechnology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.